With an anticipated $2B IPO and love from Apple, digital health may finally get respect

Article Highlights

  • For the last five years or so, digital health has been the Rodney Dangerfield of investment sectors

    Tweet This

  • Apple is starting to take healthcare very seriously

    Tweet This

  • Digital health’s potential may finally be too tactile for consumers, investors, and even medical product companies to responsibly ignore

    Tweet This

 

 

For the last five years or so, digital health has been the Rodney Dangerfield of investment sectors, getting more attention than respect, and garnering more page views than dollars.

However, two important events reported in the last several days suggest all this may be about to change.

First, Fortune’s Dan Primack broke the news on Saturday that Castlight Health — a startup co-founded by U.S. Chief Technology Officer Todd Park in 2008, with the intention of providing increased transparency to healthcare costs – has secretly filed an IPO; an astonishing valuation of around $2B is anticipated.   That’s both impressive growth and serious money, and suggests it’s possible to win – and win big – in digital health.

Second, two complimentary reports from last Friday collectively suggest that Apple is starting to take healthcare very seriously.

For starters, the New York Times reported that Apple executives met with the FDA in December 2013 to discuss mobile medical applications.

In addition, 9to5Mac, a website devoted to “Apple Intelligence,” claimed that the next version of the iPhone operating system, iOS8 – slated for release later this year – will introduce an application codenamed “Healthbook” that is “capable of monitoring and storing fitness statistics such as steps taken, calories burned, and miles walked,” according to 9to5Mac.  This operating system is also anticipated to facilitate integration with Apple’s rumored “iWatch,” a device expected to come equipped with an impressive range of health-monitoring capabilities.

Apple’s pursuit of health – and especially FDA-worthy products, if they materialize – has the potential to be game-changing, though a key issue, as Union Square Venture’s Fred Wilson perceptively observed, is “whether Apple will make it easy to get our data out.”

In other words, will Apple emulate Epic, a notoriously closed EMR (see hereand here) that’s earned the enmity of many (including Rock Health’s Co-Founder and CEO Halle Tecco, who pointed out at a recent, exceptional DFJ Entrepreneurial Thought Leader talk that the Epic systems at UCSF and Stanford apparently can’t even communicate with each other), but has built a tremendously successful product and business?  Or will Apple try to build a more open ecosystem, as championed by most other EMR vendors, who tend to celebrate interoperability but often struggle for revenue.

It’s also important to recognize that, gadgets, apps, and breathless tech headlines not withstanding, Silicon Valley hasn’t disrupted healthcare – not even close.   Disruption ultimately requires credible evidence of either improved outcomes, reduced costs, or both, yet turning information into impact is exceptionally difficult.  We should celebrate passion – but not confuse it with the progress we hope it enables.

The promise, however, is unmistakable.  Between Castlight’s anticipated $2B exit and Apple’s enthusiastic embrace, digital health’s robust potential may finally be too tactile for consumers, investors, and even medical product companies to responsibly ignore.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

David
Shaywitz
  • Dr. Shaywitz trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco. He recently wrote Tech Tonics: Can Passionate Entreprenuers Heal Healthcare With Technology? 

  • Email: davidshaywitz.aei@gmail.com

What's new on AEI

image Getting it right: US national security policy and al Qaeda since 2011
image Net neutrality rundown: What the NPRM means for you
image The Schuette decision
image Snatching failure from victory in Afghanistan
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Event Registration is Closed
Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.